The role of programmed cell death in renal cancer: a bibliometric perspective (1998–2024)
PCD research in renal cancer has evolved into a dynamic, interdisciplinary domain integrating immunology, molecular targeting, and multi-omic profiling. Future development of the field aimed at refining precision therapies that exploit diverse cell death mechanisms and thereby improve clinical outcomes.
Authors
- Xiaorong Hu (ORCID: https://orcid.org/0000-0002-9378-3715)
- Liang Hong (ORCID: https://orcid.org/0000-0002-3489-0633)
- Xueyao Li
- Li Lü (ORCID: https://orcid.org/0000-0003-0915-1588)
- Chun Zhao (ORCID: https://orcid.org/0000-0003-4925-8793)
- Tingping Wu
Institutions
- Tibet Autonomous Region People's Hospital (CN)
- Chongqing Dazu District People's Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1007/s12672-025-02610-3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00